Neurological disorders that affect the nerves or muscles of the eyes — such as myasthenia gravis — can also lead to ptosis. The main symptom of droopy eyelid is that one or both upper eyelids sag.

and cerebrovascular system if ptosis is accompanied by other neurological deficits or examination of serum antibodies to ...

Myasthenia gravis (MG) is a neuromuscular junction disorder clinically ... A 61-year-old male was first diagnosed with gMG in April 2023, when he presented with left-sided ptosis. The patient’s ...

Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.

People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles ...

Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.

Generalised myasthenia gravis (gMG) is a chronic disorder in which the body's immune system mistakenly targets the neuromuscular junctions—areas where nerves signal muscles to move. This ...

Interim data from phase 2 KYSA-6 study, using KYV-101 for the treatment of patients with Myasthenia Gravis, expected 2nd half of 2025. Click here to read more.